Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Clinical trial NCT00035334 · COMPLETED

Trial details

NCT number: NCT00035334
Sponsor: Bellus Health Inc. - a GSK company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Secondary (AA) Amyloidosis Rheumatoid Arthritis Nephrotic Syndrome Familial Mediterranean Syndrome Kidney Diseases Gastrointestinal Diseases

Start date: 2001-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.